Demand for the Anthropic IPO Far Outpaces Available Shares. Be Careful in an Early Scramble for Stock.

Barchart
Barchart에서 열기
Demand for the Anthropic IPO Far Outpaces Available Shares. Be Careful in an Early Scramble for Stock.

Buying shares in Anthropic (ANT) could soon become an option for everyday investors as its upcoming initial public offering (IPO) draws Wall Street’s attention. The Nasdaq 100 ($IUXX) jumped on Nov. 11 as encouraging artificial intelligence (AI) earnings and strong demand for Anthropic’s upcoming IPO helped lift market sentiment.

Anthropic, the AI company behind Claude, is preparing to list under the ticker “ANT,” giving public market investors a chance to own a stake in the business. But the opportunity to buy and the ability to secure shares on attractive terms are two different things.

More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.

 

With so many investors eager to get in, what could the competition for shares mean for the allocation you receive and the price you ultimately pay? Let’s find out.

What Oversubscription Means for Retail Buyers

Anthropic’s IPO has attracted orders for multiple times the available shares, meaning investors have requested more stock than the offering can accommodate. Bankers have reportedly told prospective buyers that existing backers will receive priority, potentially leaving newcomers with smaller allocations than they hoped to secure ahead of the company’s public debut.

Individual investors nevertheless have a designated opening. Anthropic plans to allocate up to 20% of its offering's 825 million shares to retail buyers. That represents as many as 165 million shares, worth approximately $12.2 billion at the proposed $74 midpoint per-share price. However, the final retail allocation remains subject to demand, so those figures represent a potential maximum rather than a guaranteed pool of shares available to individual applicants.

Even within that pool, buyers could receive fewer shares than requested or miss out altogether. Overall oversubscription does not reveal an applicant’s allocation odds, and the reported preference for existing backers does not establish how the separate retail allocation will be distributed.

Buyers who miss out may consider purchasing once trading begins, but an early premium could later fade. Retail investors, therefore, face uncertainty over both access and price. They may secure a smaller initial stake than planned, then pay more to complete their position, increasing their average purchase cost and the risk of losses if early enthusiasm gives way to selling.

What Anthropic Is Bringing to Market

Anthropic expects to begin trading on the Nasdaq on Nov. 19. The offering comprises 801.4 million new Class A shares and 23.6 million shares from existing holders, whose proceeds will not go to the company. Underwriters have a 30-day option to purchase another 123.75 million shares.

The proposed $70 to $78 price range implies a valuation of approximately $1.3 trillion at the midpoint and $1.4 trillion at the upper end. At the highest proposed price, the public offering could generate approximately $64.4 billion in gross proceeds. Combined with a separate $26 billion Class N private placement, gross transaction proceeds could reach $90.4 billion. Final pricing remains pending.

Behind those figures is a rapidly expanding business with substantial spending obligations. Anthropic’s revenue reached $33.2 billion in the first nine months of 2026, compared with $2.5 billion in the same period of 2025. 

Supporting that growth requires substantial investment, with computing and infrastructure commitments totaling $895.4 billion through 2045, including $447.5 billion expected by the end of 2030. The company's reported $3.4 billion deal covering 1.7 gigawatts of generator capacity further illustrates the power requirements behind that expansion.

Despite this growth, valuation expectations have shifted ahead of the listing. On Hyperliquid, a derivative tracking Anthropic’s implied valuation fell nearly 30% from its September peak. That movement reflects speculative contract pricing rather than a decline in publicly traded Anthropic shares.

Alongside its commercial expansion, Anthropic has committed 5% of its shares to a public benefit fund. Together with other philanthropic pledges, approximately 20% of company shares are dedicated to “public good” initiatives, extending its public benefit mission into its financial commitments.

What Analysts Make of Investor Appetite

The rush for Anthropic shares has reportedly led Goldman Sachs and Morgan Stanley to consider pricing the offering above the proposed $78 ceiling. That suggests the banks leading the deal see room to ask buyers for more, although their confidence in selling the shares differs from an independent assessment of their value.

That distinction becomes clearer when looking at the skeptics. Research firm New Constructs called the offering the “most ridiculous IPO of 2026,” questioning whether customer spending can support Anthropic’s substantial computing obligations. The concern is that the company has committed to infrastructure costs without securing equally durable customer revenue commitments.

Michael Burry shares that concern. He warned that Anthropic is “betting its entire existence on that optimism,” pointing to contracts that require payment for computing capacity even when it isn't needed. Those obligations could squeeze margins if demand disappoints. Burry said he had no plans to pursue shares.

Jim Osman, founder of The Edge Group and a specialist in spinoffs and other corporate restructuring opportunities, leaves more room for the business to prove itself. He recognizes Anthropic’s growth but wants clearer evidence of sustainable margins and what shareholders retain after infrastructure suppliers are paid.

Conclusion

Anthropic’s crowded IPO means retail buyers could receive fewer shares than requested or pay more once trading begins. The likeliest outcome is an early scramble for shares, followed by closer scrutiny of whether earnings prospects justify the price. That leaves buyers balancing limited access against the risk of overpaying. Missing an allocation could feel frustrating, but chasing a jump would add another risk. The better outcome is owning shares at a price that makes sense, even if that means waiting. 


On the date of publication, Ebube Jones did not directly have a position in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.

 

More news from Barchart

Demand for the Anthropic IPO Far Outpaces Available Shares. Be Careful in an Early Scramble for Stock. Option Volatility and Earnings Report For Nov 16-20 U.S. Futures Slip as Chip Stocks Extend Slump; Nvidia Earnings and Anthropic IPO Awaited Could Last Friday's Events Have Ripple Effects for This Week's Markets?